Table 2.

Correlation between the Fat Fraction and Other Variables (Pearson's Correlation Analysis)

Variable	NAFLD			All HBV			HBV without AVT			HBV with AVT
	Correlation coefficient	p-value		Correlation coefficient	p-value		Correlation coefficient	p-value		Correlation coefficient	p-value
Age, yr	–0.608	<0.001		–0.111	0.082		–0.080	0.544		–0.160	0.030
Male sex	0.151	0.245		0.004	0.949		0.023	0.861		–0.019	0.802
BMI, kg/m2	0.063	0.629		0.229	<0.001		0.409	0.001		0.112	0.129
Hypertension	–0.345	0.007		–0.045	0.482		–0.064	0.627		–0.050	0.500
Diabetes	0.031	0.810		0.063	0.325		0.086	0.515		0.050	0.502
Liver cirrhosis	–0.471	<0.001		–0.266	<0.001		–0.252	0.052		–0.249	0.001
Dyslipidemia	–0.188	0.148		0.164	0.010		0.545	<0.001		0.005	0.942
Total bilirubin, mg/dL	–0.208	0.108		–0.077	0.229		–0.042	0.750		–0.103	0.162
Serum albumin, g/dL	0.347	0.006		0.122	0.057		0.206	0.114		0.087	0.240
Aspartate aminotransferase, U/L	0.037	0.779		0.080	0.213		0.228	0.080		0.010	0.890
Alanine aminotransferase, U/L	0.262	0.042		0.118	0.066		0.414	0.001		0.025	0.731
Total cholesterol, mg/dL	0.367	0.004		0.141	0.029		0.127	0.338		0.136	0.067
Platelet count, ×109/L	0.557	<0.001		0.268	<0.001		0.375	0.003		0.203	0.007
Prothrombin time, INR	–0.221	0.259		–0.055	0.506		–0.101	0.551		–0.051	0.597
Hepatic steatosis index	0.382	0.002		0.256	<0.001		0.469	<0.001		0.138	0.062

NAFLD, nonalcoholic fatty liver disease; HBV, hepatitis B virus; AVT, antiviral therapy; BMI, body mass index; INR, international normalized ratio.